纳武单抗诱发暴发性1型糖尿病（T1D）：首例意大利病例报告，随访时间长且采用动态血糖监测 - Suppr | 超能文献

相似文献

1

Nivolumab-induced fulminant type 1 diabetes (T1D): the first Italian case report with long follow-up and flash glucose monitoring.纳武单抗诱发暴发性1型糖尿病（T1D）：首例意大利病例报告，随访时间长且采用动态血糖监测

Acta Diabetol. 2019 Apr;56(4):489-490. doi: 10.1007/s00592-018-1246-4. Epub 2018 Oct 25.

2

Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.纳武利尤单抗致暴发性 1 型糖尿病伴 C 肽水平急剧下降

J Diabetes Investig. 2020 May;11(3):748-749. doi: 10.1111/jdi.13143. Epub 2019 Oct 6.

3

Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.一名黑色素瘤患者在接受纳武单抗治疗后使用伊匹单抗治疗时发生1型糖尿病。

J Dermatol. 2018 Oct;45(10):e289-e290. doi: 10.1111/1346-8138.14331. Epub 2018 Apr 18.

4

Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment.两例免疫检查点抑制剂治疗停止后很久才发生的暴发性 1 型糖尿病。

J Diabetes Investig. 2022 Aug;13(8):1458-1460. doi: 10.1111/jdi.13807. Epub 2022 Apr 29.

5

Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report.纳武单抗诱发的急性1型糖尿病作为一种免疫相关不良事件：一例报告

J Oncol Pharm Pract. 2019 Dec;25(8):2023-2026. doi: 10.1177/1078155218816777. Epub 2018 Dec 8.

6

Peroral cholangioscopy of nivolumab-related (induced) ulcerative cholangitis in a patient with non-small cell lung cancer.非小细胞肺癌患者中纳武利尤单抗相关（诱导性）溃疡性胆管炎的经口胆管镜检查

Endoscopy. 2018 Sep;50(9):E259-E261. doi: 10.1055/a-0640-2392. Epub 2018 Jul 3.

7

A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia.一名患有与纳武单抗相关的暴发性1型糖尿病的患者，其血清C肽水平在高血糖初次检测时保持正常。

Intern Med. 2019 Oct 1;58(19):2825-2830. doi: 10.2169/internalmedicine.2780-19. Epub 2019 Jun 27.

8

Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.纳武利尤单抗诱发的吉兰-巴雷综合征合并在一名经过大量预处理的肺腺癌患者中出现显著疾病反应

Clin Lung Cancer. 2020 Mar;21(2):e65-e73. doi: 10.1016/j.cllc.2019.11.001. Epub 2019 Nov 21.

9

Feasibility of FreeStyle Libre Flash Glucose Monitoring System in pregnant woman affected by type 1 diabetes.Freestyle Libre 闪式葡萄糖监测系统在 1 型糖尿病孕妇中的可行性

Acta Diabetol. 2019 Apr;56(4):481-483. doi: 10.1007/s00592-018-1252-6. Epub 2018 Nov 11.

10

Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic.动态血糖监测改善1型糖尿病门诊治疗效果。

J Diabetes Sci Technol. 2017 Mar;11(2):442-443. doi: 10.1177/1932296816661560. Epub 2016 Jul 28.

引用本文的文献

1

Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review.成功治疗纳武利尤单抗和伊匹单抗引发的 1 型糖尿病：病例报告和系统评价。

Front Public Health. 2023 Dec 1;11:1264056. doi: 10.3389/fpubh.2023.1264056. eCollection 2023.

2

Clinical and immunological characteristics of PD-1 associated fulminant type 1 diabetes mellitus.PD-1 相关暴发性 1 型糖尿病的临床和免疫学特征。

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Jan 28;48(1):49-58. doi: 10.11817/j.issn.1672-7347.2023.220290.

3

Diabetic ketoacidosis induced by nivolumab in invasive mucinous adenocarcinoma of the lung: a case report and review of the literature.